# Living With Sickle Cell Disease in the COVID-19 Pandemic

> **NCT04417673** · — · COMPLETED · sponsor: **National Human Genome Research Institute (NHGRI)** · enrollment: 186 (actual)

## Conditions studied

- Isolation
- Anxiety
- Health Care Utilization
- Sickle Cell Disease
- Pain

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04417673
- **Lead sponsor:** National Human Genome Research Institute (NHGRI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-15
- **Primary completion:** 2022-05-18
- **Final completion:** 2022-05-18
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04417673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04417673, "Living With Sickle Cell Disease in the COVID-19 Pandemic". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04417673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*